|
1
|
Matthay KK, Maris JM, Schleiermacher G,
Nakagawara A, Mackall CL, Diller L and Weiss WA: Neuroblastoma. Nat
Rev Dis Primers. 2:160782016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel DA, King J, Tai E, Buchanan N,
Ajani UA and Li J: Cancer incidence rates and trends among children
and adolescents in the United States, 2001–2009. Pediatrics.
134:e945–e955. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morandi F, Corrias MV and Pistoia V:
Evaluation of bone marrow as a metastatic site of human
neuroblastoma. Ann N Y Acad Sci. 1335:23–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pinto NR, Applebaum MA, Volchenboum SL,
Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F,
Schleiermacher G, Park JR, et al: Advances in risk classification
and treatment strategies for neuroblastoma. J Clin Oncol.
33:3008–3017. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu L, Sun F, Sun Z, Ni X, Wang J, Wang J,
Zhou M, Feng Y, Kong Z, Hua Q and Yu J: Apatinib enhances the
radiosensitivity of the esophageal cancer cell line KYSE-150 by
inducing apoptosis and cell cycle redistribution. Oncol Lett.
17:1609–1616. 2019.PubMed/NCBI
|
|
6
|
Tian S, Quan H, Xie C, Guo H, Lü F, Xu Y,
Li J and Lou L: YN968D1 is a novel and selective inhibitor of
vascular endothelial growth factor receptor-2 tyrosine kinase with
potent activity in vitro and in vivo. Cancer Sci. 102:1374–1380.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu K, Ren T, Huang Y, Sun K, Bao X, Wang
S, Zheng B and Guo W: Apatinib promotes autophagy and apoptosis
through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma. Cell Death
Dis. 8:e30152017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jin Z, Cheng X, Feng H, Kuang J, Yang W,
Peng C, Shen B and Qiu W: Apatinib inhibits angiogenesis via
suppressing Akt/GSK3β/ANG signaling pathway in anaplastic thyroid
cancer. Cell Physiol Biochem. 44:1471–1484. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang C and Qin S: Apatinib targets both
tumor and endothelial cells in hepatocellular carcinoma. Cancer
Med. 7:4570–4583. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin C, Wang S, Xie W, Zheng R, Gan Y and
Chang J: Apatinib inhibits cellular invasion and migration by
fusion kinase KIF5B-RET via suppressing RET/Src signaling pathway.
Oncotarget. 7:59236–59244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Qin S, Xu J, Xiong J, Wu C, Bai Y,
Liu W, Tong J, Liu Y, Xu R, et al: Randomized, double-blind,
placebo-controlled phase III trial of apatinib in patients with
chemotherapy-refractory advanced or metastatic adenocarcinoma of
the stomach or gastroesophageal junction. J Clin Oncol.
34:1448–1454. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng H, Cheng X, Kuang J, Chen L, Yuen S,
Shi M, Liang J, Shen B, Jin Z, Yan J and Qiu W: Apatinib-induced
protective autophagy and apoptosis through the AKT-mTOR pathway in
anaplastic thyroid cancer. Cell Death Dis. 9:10302018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang M, Huang B, Li G and Zeng S:
Apatinib affect VEGF-mediated cell proliferation, migration,
invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in
cholangiocarcinoma cell. BMC Gastroenterol. 18:1692018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Santo EE, Stroeken P, Sluis PV, Koster J,
Versteeg R and Westerhout EM: FOXO3a is a major target of
inactivation by PI3K/AKT signaling in aggressive neuroblastoma.
Cancer Res. 73:2189–2198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mei H, Wang Y, Lin Z and Tong Q: The mTOR
signaling pathway in pediatric neuroblastoma. Pediatr Hematol
Oncol. 30:605–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lambertz I, Kumps C, Claeys S, Lindner S,
Beckers A, Janssens E, Carter DR, Cazes A, Cheung BB, De Mariano M,
et al: Upregulation of MAPK negative feedback regulators and RET in
mutant ALK neuroblastoma: Implications for targeted treatment. Clin
Cancer Res. 21:3327–3339. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang XR, Yu XY, Fan JH, Guo L, Zhu C,
Jiang W and Lu SH: RFT2 is overexpressed in esophageal squamous
cell carcinoma and promotes tumorigenesis by sustaining cell
proliferation and protecting against cell death. Cancer Lett.
353:78–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xue L, Yu X, Jiang X, Deng X, Mao L, Guo
L, Fan J, Fan Q, Wang L and Lu SH: TM4SF1 promotes the self-renewal
of esophageal cancer stem-like cells and is regulated by miR-141.
Oncotarget. 8:19274–19284. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu HB, Yang S, Weng HY, Chen Q, Zhao XL,
Fu WJ, Niu Q, Ping YF, Wang JM, Zhang X, et al: Autophagy-induced
KDR/VEGFR-2 activation promotes the formation of vasculogenic
mimicry by glioma stem cells. Autophagy. 13:1528–1542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong Z, Zhu C, Zhan Q and Jiang W: Cdk
phosphorylation licenses Kif4A chromosome localization required for
early mitotic progression. J Mol Cell Biol. 10:358–370. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun J, Huang W, Yang SF, Zhang XP, Yu Q,
Zhang ZQ, Yao J, Li KR, Jiang Q and Cao C: Gαi1 and Gαi3mediate
VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis.
Theranostics. 8:4695–4709. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Larrue C, Saland E, Boutzen H, Vergez F,
David M, Joffre C, Hospital MA, Tamburini J, Delabesse E, Manenti
S, et al: Proteasome inhibitors induce FLT3-ITD degradation through
autophagy in AML cells. Blood. 127:882–892. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Deng M, Chen Q, Li Y, Guo X, Shi
P, He L, Xie S, Yu L, Zhang H and Xu B: Apatinib exerts anti-tumor
activity to non-Hodgkin lymphoma by inhibition of the Ras pathway.
Eur J Pharmacol. 843:145–153. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu H, Li J, Liu Q, Tang M and Wang Y:
Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor
growth in cervical cancer and synergizes with paclitaxel. Cell
Cycle. 17:1235–1244. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weilbaecher KN, Guise TA and McCauley LK:
Cancer to bone: A fatal attraction. Nat Rev Cancer. 11:411–425.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Viprey VF, Gregory WM, Corrias MV,
Tchirkov A, Swerts K, Vicha A, Dallorso S, Brock P, Luksch R,
Valteau-Couanet D, et al: Neuroblastoma mRNAs predict outcome in
children with stage 4 neuroblastoma: A European HR-NBL1/SIOPEN
study. J Clin Oncol. 32:1074–1083. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McTigue M, Murray BW, Chen JH, Deng YL,
Solowiej J and Kania RS: Molecular conformations, interactions, and
properties associated with drug efficiency and clinical performance
among VEGFR TK inhibitors. Proc Natl Acad Sci USA. 109:18281–18289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rössler J, Monnet Y, Farace F, Opolon P,
Daudigeos-Dubus E, Bourredjem A, Vassal G and Geoerger B: The
selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor
activity in human neuroblastoma xenografts. Int J Cancer.
128:2748–2758. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kakodkar NC, Peddinti RR, Tian Y, Guerrero
LJ, Chlenski A, Yang Q, Salwen HR, Maitland ML and Cohn SL:
Sorafenib inhibits neuroblastoma cell proliferation and signaling,
blocks angiogenesis, and impairs tumor growth. Pediatr Blood
Cancer. 59:642–647. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nilsson MB, Zage PE, Zeng L, Xu L, Cascone
T, Wu HK, Saigal B, Zweidler-McKay PA and Heymach JV: Multiple
receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in
normoxia and hypoxia in neuroblastoma: Implications for
antiangiogenic mechanisms of multikinase inhibitors. Oncogene.
29:2938–2949. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng X, Feng H, Wu H, Jin Z, Shen X,
Kuang J, Huo Z, Chen X, Gao H, Ye F, et al: Targeting autophagy
enhances apatinib-induced apoptosis via endoplasmic reticulum
stress for human colorectal cancer. Cancer Lett. 431:105–114. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mukhopadhyay S, Panda PK, Sinha N, Das DN
and Bhutia SK: Autophagy and apoptosis: Where do they meet?
Apoptosis. 19:555–566. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hydbring P, Malumbres M and Sicinski P:
Non-canonical functions of cell cycle cyclins and cyclin-dependent
kinases. Nat Rev Mol Cell Biol. 17:280–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thorpe LM, Yuzugullu H and Zhao JJ: PI3K
in cancer: Divergent roles of isoforms, modes of activation and
therapeutic targeting. Nat Rev Cancer. 15:7–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Simons M, Gordon E and Claesson-Welsh L:
Mechanisms and regulation of endothelial VEGF receptor signalling.
Nat Rev Mol Cell Biol. 17:611–625. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Levy JMM, Towers CG and Thorburn A:
Targeting autophagy in cancer. Nat Rev Cancer. 17:528–542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hansen M, Rubinsztein DC and Walker DW:
Autophagy as a promoter of longevity: Insights from model
organisms. Nat Rev Mol Cell Biol. 19:579–593. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang G, Wang Z, Du Z and Zhang H: mTOR
regulates phase separation of PGL granules to modulate their
autophagic degradation. Cell. 174:1492–1506 e22. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
You L, Wang Z, Li H, Shou J, Jing Z, Xie
J, Sui X, Pan H and Han W: The role of STAT3 in autophagy.
Autophagy. 11:729–739. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ohsumi Y: Historical landmarks of
autophagy research. Cell Res. 24:9–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin
MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD,
Adeli K, et al: Guidelines for the use and interpretation of assays
for monitoring autophagy (3rd edition). Autophagy. 12:1–222. 2016.
View Article : Google Scholar : PubMed/NCBI
|
